WELCOME TO

THE ORGANON ACCESS PROGRAM

ARE YOU A US HEALTH CARE PROFESSIONAL?
The Organon Access Program for RENFLEXIS® (infliximab-abda)
RENFLEXIS® (infliximab-abda) for injection, for intravenous use 100 mg
Physician Prescribing Information Medication Guide
Health Care Professionals Patients and Caregivers
Medication Guide Physician Prescribing Information
The Organon Access Program for RENFLEXIS® (infliximab-abda)
Before prescribing RENFLEXIS, please read
the accompanying Prescribing Information, including the Boxed Warning about serious infections and malignancies.
The Medication Guide also is available.
RENFLEXIS® (infliximab-abda) for injection, for intravenous use 100 mg
MENU
  • ENROLL NOW
  • Home for The Organon Access Program for RENFLEXIS® (infliximab-abda)
  • Home
  • Coding & Billing
  • Coverage &
    Reimbursement Support
  • Financial Assistance
    • The Organon Co-pay Assistance Program
    • The Organon Patient Assistance Program
    • Co-pay Claims Portal
  • Resources
ENROLL NOW
Contact The Organon
Access Program at 866-847-3539
Mon-Fri 8 AM to 8 PM ET

THE ORGANON CO-PAY ASSISTANCE PROGRAM FOR RENFLEXIS

The Organon Co-pay Assistance Program offers assistance to eligible patients who need help affording the out-of-pocket costs for RENFLEXIS.

  • Once enrolled, eligible, privately insured patients pay the first $5 of their co-pay per infusion
  • Maximum co-pay assistance program benefit per calendar year is determined by Organon

Co-pay assistance from Organon Co-pay Assistance Program is not insurance. Restrictions apply. See Terms and Conditions.

Co-pay assistance may be available for patients who:
  • Are a resident of the United States (including Puerto Rico)
  • Have been prescribed RENFLEXIS for an FDA-approved indication
  • Have private health insurance that provides coverage for RENFLEXIS
  • Meet all other Terms and Conditions of the program
  • Are a resident of the United States (including Puerto Rico)
  • Have private health insurance that provides coverage for RENFLEXIS
  • Have been prescribed RENFLEXIS for an FDA-approved indication
  • Meet all other Terms and Conditions of the program

The Organon Co-pay Assistance Program is not valid for patients covered under a Government Program, as that term is defined in the Terms and Conditions. The Organon Co-pay Assistance Program is not valid for uninsured patients.

Patient and health care professional must submit all required information. Please see the enrollment form for details.

ENROLL NOW

Other financial support options for RENFLEXIS

What if my patient is not eligible for the Organon Co-pay Assistance Program?

Your patient may be able to get help from an independent co-pay assistance foundation. A representative can provide you with information about independent foundations that may be able to provide financial support to patients who do not qualify for the Organon Co-pay Assistance Program. Each independent foundation has its own eligibility criteria and application process.

Potential Independent Foundation Support for RENFLEXIS® (infliximab-abda)

Questions? Contact The Organon Access Program at 866-847-3539 Mon-Fri 8 AM to 8 PM ET to speak to a representative.

Organon Co-pay Assistance Program for RENFLEXIS® (infliximab-abda) for injection, for intravenous use 100 mg (Effective January 1, 2023)

Terms and Conditions

The Organon Co-pay Assistance Program ("Co-pay Assistance Program") for RENFLEXIS consists of two sets of Terms and Conditions, one applicable to RENFLEXIS for which a claim is submitted by a patient’s health care provider (“Medical Benefit”) and the other applicable to RENFLEXIS purchased by a patient at a participating pharmacy (“Pharmacy Benefit”). Both sets of Terms and Conditions for the Co-pay Assistance Program for RENFLEXIS are set forth below.

Terms and Conditions – RENFLEXIS – (Medical Benefit):

  • To receive benefits under the Organon Co-pay Assistance Program (“Co-pay Assistance Program”) for RENFLEXIS (“Program Product”), the patient must enroll in the Co-pay Assistance Program and be accepted as eligible.
  • Patient must be prescribed the Program Product for an FDA-approved indication.
  • Patient must have private health insurance that provides coverage for the cost of the Program Product under a medical benefit plan.
  • The Co-pay Assistance Program is not valid for patients covered under Medicaid (including Medicaid patients enrolled in a qualified health plan purchased through a health insurance exchange [marketplace] established by a state government or the federal government), Medicare, a Medicare Part D or Medicare Advantage plan (regardless of whether a specific prescription is covered), TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan (“Healthcare Reform”), or any other state or federal medical or pharmaceutical benefit program or pharmaceutical assistance program (collectively, “Government Programs”). The Co-pay Assistance Program is not valid for uninsured patients.
  • Subject to changes in state law, the Co-pay Assistance Program may become invalid for residents of Massachusetts prior to its expiration date.
  • Patient must have an out-of-pocket cost for the Program Product and be administered the Program Product prior to the expiration date of the Co-pay Assistance Program. The benefit available under the Co-pay Assistance Program is valid for the patient’s out-of-pocket cost for the Program Product only. It is not valid for any other out-of-pocket costs (for example, office visit charges or medication administration charges) even if such costs are associated with the administration of the Program Product. Claim for Program Product must be submitted by health care provider to patient’s private health insurance separately from other services and products.
  • Patient must pay the first $5 of co-pay per administration of Program Product. The benefit available under the Co-pay Assistance Program is limited to the amount the patient’s private health insurance company indicates on the Explanation of Benefits ("EOB") that the patient is obligated to pay for the Program Product, less $5, up to an annual maximum. The annual maximum for each eligible patient is determined by Organon in its sole discretion and may be changed at any time and for any reason. The annual maximum shall be disclosed to each patient when the patient calls into the following number: 866-847-3539. Organon will disclose the annual maximum as required by applicable law.
  • An EOB from patient’s private health insurance must be submitted within 180 days of the date of the EOB for patient to receive co-pay assistance benefit; provided, however, that no EOB may be submitted more than 180 days after the expiration date of the Co-pay Assistance Program. The EOB must reflect the patient’s out-of-pocket cost for the Program Product and submission of the claim by the patient’s health care provider for the cost of the Program Product.
  • Patient and health care provider agree not to seek reimbursement for all or any part of the benefit received by the patient through the Co-pay Assistance Program. Patient and health care provider are responsible for reporting receipt of Co-pay Assistance Program benefits to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost paid for by the Co-pay Assistance Program, as may be required.
  • Patient must be a resident of the United States or the Commonwealth of Puerto Rico. Program Product must originate and be administered to patient in the United States or the Commonwealth of Puerto Rico.
  • The Co-pay Assistance Program may apply to patient out-of-pocket costs incurred for Program Product within 180 days prior to the date patient is enrolled in the Co-pay Assistance Program, subject to annual Co-pay Assistance Program maximum and the applicable Terms and Conditions based on Program Product administration date. Patient or health care provider may contact The Organon Access Program for more information.
  • All information applicable to the Co-pay Assistance Program requested on the enrollment form must be provided, and all certifications must be signed. Forms that are modified or do not contain all the necessary information will not be eligible for benefits under the Co-pay Assistance Program.
  • No other purchase is necessary.
  • The Co-pay Assistance Program is not insurance.
  • The Co-pay Assistance Program form may not be sold, purchased, traded, or counterfeited. Void if reproduced.
  • The Co-pay Assistance Program is void where prohibited by law, taxed, or restricted. The Co-pay Assistance Program is not transferable. No substitutions are permitted.
  • The Co-pay Assistance Program benefit cannot be combined with any other co-pay assistance programs, free trial, discount, prescription savings card, or other offer. Benefits are not available through this Co-pay Assistance Program for RENFLEXIS purchased by patient at a pharmacy. Co-pay assistance may be available from Organon for RENFLEXIS purchased by patient at a pharmacy through separate Terms and Conditions, provided, however, that the per-patient annual maximum Co-pay Assistance Program benefit for RENFLEXIS across these Terms and Conditions has not been exceeded.
  • Organon reserves the right to rescind, revoke, or amend the Co-pay Assistance Program at any time without notice.
  • Data related to patient’s receipt of Co-pay Assistance Program benefits may be collected, analyzed, and shared with Organon, for market research and other purposes related to assessing co-pay assistance programs. Data shared with Organon will be aggregated and de-identified, meaning it will be combined with data related to other co-pay assistance program redemptions and will not identify patient.
  • These Terms and Conditions are valid for Program Product administered between January 1, 2023, and December 31, 2023.
  • Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning about serious infections and malignancies. The Medication Guide also is available.
  • Expiration Date: 12/31/2023.

Terms and Conditions – RENFLEXIS – (Pharmacy Benefit):

  • To receive benefits under the Organon Co-pay Assistance Program (“Co-pay Assistance Program”) for RENFLEXIS (“Program Product”), the patient must enroll in the Co-pay Assistance Program and be accepted as eligible.
  • Patient must be prescribed the Program Product for an FDA-approved indication.
  • Patient must have private health insurance that provides coverage for the cost of the Program Product purchased by the patient at an eligible participating pharmacy.
  • The Co-pay Assistance Program is not valid for patients covered under Medicaid (including Medicaid patients enrolled in a qualified health plan purchased through a health insurance exchange [marketplace] established by a state government or the federal government), Medicare, a Medicare Part D or Medicare Advantage plan (regardless of whether a specific prescription is covered), TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan ("Healthcare Reform"), or any other state or federal medical or pharmaceutical benefit program or pharmaceutical assistance program (collectively, "Government Programs"). The Co-pay Assistance Program is not valid for uninsured patients.
  • Subject to changes in state law, the coupon may become invalid for residents of Massachusetts prior to its expiration date.
  • Patient must have an out-of-pocket cost for the Program Product and purchase the Program Product prior to the expiration date of the Co-pay Assistance Program. Patient must pay the first $5 of co-pay on each prescription for Program Product (regardless of quantity supplied on the prescription). The benefit available under the Co-pay Assistance Program is limited to the amount of the patient’s actual out-of-pocket cost over $5, on each prescription, up to an annual maximum. The annual maximum for each eligible patient is determined by Organon in its sole discretion and may be changed at any time and for any reason. The annual maximum shall be disclosed to each patient when the patient calls into the following number: 866-847-3539. Organon will disclose the annual maximum as required by applicable law. The benefit available under Co-pay Assistance Program is valid for the patients out-of-pocket cost for the Program Product only. It is not valid for any other out-of-pocket costs (for example, office visit charges or medication administration charges) even if such costs are associated with the administration of the Program Product.
  • The Co-pay Assistance Program coupon benefit cannot be combined with any other co-pay assistance programs, free trial, discount, prescription savings card, or other offer. Benefits are not available through these Terms and Conditions for RENFLEXIS for which a claim was submitted by a health care provider to a patient’s private health insurance company. Co-pay assistance may be available from Organon for RENFLEXIS for which a claim was submitted by a health care provider to a patient’s private health insurance company through separate Terms and Conditions, provided, however, that the per-patient annual maximum Co-pay Assistance Program benefit for RENFLEXIS across these Terms and Conditions has not been exceeded.
  • Patient, pharmacist, and prescriber agree not to seek reimbursement for all or any part of the benefit received by the patient through the Co-pay Assistance Program. Patient is responsible for reporting receipt of Co-pay Assistance Program coupon benefits to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost paid for by the Co-pay Assistance Program, as may be required.
  • Co-pay Assistance Program coupon can be redeemed only by eligible residents of the United States or the Commonwealth of Puerto Rico at participating eligible retail or mail-order pharmacies in the United States or the Commonwealth of Puerto Rico. Program Product must originate in the United States or the Commonwealth of Puerto Rico.
  • Co-pay Assistance Program benefits are not available for patient costs incurred prior to the date the patient is determined to be eligible under and enrolled in the Co-pay Assistance Program.
  • All information applicable to the Co-pay Assistance Program requested on the enrollment form must be provided, and all certifications must be signed. Forms that are modified or do not contain all the necessary information will not be eligible for benefits under the Co-pay Assistance Program.
  • No other purchase is necessary.
  • The Co-pay Assistance Program is not insurance.
  • The Co-pay Assistance Program coupon may not be sold, purchased, traded, or counterfeited. Void if reproduced.
  • The Co-pay Assistance Program is void where prohibited by law, taxed, or restricted. The Co-pay Assistance Program is not transferable. No substitutions are permitted.
  • Organon reserves the right to rescind, revoke, or amend the Co-pay Assistance Program at any time without notice.
  • Co-pay Assistance Program coupon is the property of Organon and must be turned in on request.
  • Data related to patient’s receipt of Co-pay Assistance Program benefits may be collected, analyzed, and shared with Organon, for market research and other purposes related to assessing co-pay assistance programs. Data shared with Organon will be aggregated and de-identified, meaning it will be combined with data related to other co-pay assistance program redemptions and will not identify patient.
  • Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning about serious infections and malignancies. The Medication Guide also is available.
  • Expiration Date: 12/31/2023.

US-SBT-115544 05/23

This site is intended only for residents of the United States.
Organon Logo
  • Terms of Use
  • Privacy Policy
  • Cookie Preferences
TRUSTe Accessibility icon

© 2023 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. US-SBT-115542 05/23

TRUSTe Accessibility icon

You will be navigating to a website outside of
The Organon Access Program.

Links to other websites are provided as a convenience to the visitor. Organon accepts no responsibility for the content of linked sites. Any data you choose to provide to the linked sites will be governed by the privacy policies of those sites.

YES NO